Zobrazeno 1 - 10
of 100
pro vyhledávání: '"V A, Lemeshko"'
Autor:
V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov
Publikováno v:
Фармакоэкономика, Vol 14, Iss 1, Pp 5-15 (2021)
Objective: the development and approbation of the method for comparative analysis of the lists of medicines in different countries and systems of healthcare.Material and methods. Based on the open-access data on the lists of medicines published on of
Externí odkaz:
https://doaj.org/article/4d3a1b6cbab54f6e9923d643b6f8e9f2
Publikováno v:
Фармакоэкономика, Vol 13, Iss 3, Pp 262-269 (2020)
Aim. Development of a tool for the evaluation of the therapeutic value of anticancer drugs based on multi-criteria analysis of decision making.Materials and methods. The study included 4 main stages. At the first stage, based on the results of the pu
Externí odkaz:
https://doaj.org/article/b7c2fb3caa264edcb6d3e2260cdcd58f
Autor:
M. Ya. Vortman, Yu. B. Pysmenna, A. V. Rudenko, V. V. Tretyak, V. N. Lemeshko, V. V. Shevchenko
Publikováno v:
Біологічні студії, Vol 14, Iss 3, Pp 65-78 (2020)
Background. Polyhexamethylene guanidines are widely used as biocides and disinfectants due to the wide range of their antimicrobial activity against Gram-positive and Gram-negative bacteria, viruses, fungi, and molds. The mechanism of biocidal action
Externí odkaz:
https://doaj.org/article/6fb0f9a4bfb94762aa5c8f456abdf9d0
Autor:
G. O Iutynska, M.Ya Vortman, D. R Abdulina, Zh. P Kopteva, A. Ye Kopteva, A. V Rudenko, V. V Tretyak, V. N Lemeshko, V. V Shevchenko
Publikováno v:
Biotechnologia Acta, Vol 13, Iss 4, Pp 60-70 (2020)
Biodegradation of various materials in the environment is important because many synthetic materials are stable for a long time. At the end of the service life, the materials must be involved in the natural cycle and decompose. In modern polymer chem
Externí odkaz:
https://doaj.org/article/778910ddc52b4a7cb2b61b4574dcf763
Publikováno v:
Фармакоэкономика, Vol 13, Iss 2, Pp 170-182 (2020)
Aim. To review foreign approaches to the evaluation and financing of in vivo gene therapy drugs.Materials and Methods. The first stage of the review included the systematic search for publications of clinical-economic studies (CES) on in vivo gene th
Externí odkaz:
https://doaj.org/article/d8ed4c51d49445b5a4cfdd7c0524f4df
Publikováno v:
Фармакоэкономика, Vol 13, Iss 1, Pp 71-83 (2020)
The article presents the description of structural, organizational and methodological issues of health technology assessment (HTA) of French drugs as well as the state-reimbursable list of drugs. The HTA is conducted by an independent public body –
Externí odkaz:
https://doaj.org/article/225d73b4875e4c75aef5208a5d51faad
Publikováno v:
Фармакоэкономика, Vol 12, Iss 3, Pp 221-229 (2019)
Introduction. The state guarantee program for provision of free medical care to citizens is a key regulatory document that describes the actual guarantees of citizens for medical care. The standards of the extent and financing of medical care establi
Externí odkaz:
https://doaj.org/article/b371f222a48b4b21a98b1b31733afa36
Publikováno v:
Фармакоэкономика, Vol 11, Iss 4, Pp 3-15 (2019)
The aim is to analyze the medical records of patients with malignant lymphoproliferative diseases (LPD) in the Russian Federation in 2016- 2017. Materials and methods. Treating physicians in 75 regions of the Russian Federation were asked to fill the
Externí odkaz:
https://doaj.org/article/336ce1b6b94c47e1a7393ec0c41f1a42
Autor:
T. P. Bezdenezhnykh, N. Z. Musina, V. K. Fedyaeva, T. S. Tepcova, V. A. Lemeshko, V. V. Omelyanovsky
Publikováno v:
Фармакоэкономика, Vol 11, Iss 4, Pp 73-80 (2019)
The article reviews international methodological guidelines, regulatory documents and existing approaches to the determination of the costeffectiveness threshold (CeT), also known as the willingness-to-pay threshold (WTP), the threshold value of the
Externí odkaz:
https://doaj.org/article/411f82ed62f849f89ce7b76edc6cc21c
Publikováno v:
Фармакоэкономика, Vol 10, Iss 4, Pp 25-30 (2018)
The current approaches to the drug pricing commonly used worldwide allow for incorporating the therapeutic value of the drug into its consumer price. The drug pricing system existing in the Russian Federation restricts the availability of highly effe
Externí odkaz:
https://doaj.org/article/cbc694845ede468bb4492485ad43040d